NFE2L2 and endothelial dysfunction: Rg3 can antagonize adriamycin-induced cardiotoxicity by improving endothelial dysfunction via upregulating the nuclear factor-erythroid 2-related factor-2 (NRF2)-antioxidant responsive element (ARE) pathway through activation of AKT (Wang et al., 2015).